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Serotonin is an ancient monoamine neurotransmitter, biochemically derived from tryptophan. It is most 
abundant in the gastrointestinal tract, but is also present throughout the rest of the body of animals and can 
even be found in plants and fungi. Serotonin is especially famous for its contributions to feelings of well-being 
and happiness. More specifically it is involved in learning and memory processes and is hence crucial for certain 
behaviors throughout the animal kingdom. This brief review will focus on the metabolism, biological role and 
mode-of-action of serotonin in insects. First, some general aspects of biosynthesis and break-down of serotonin in 
insects will be discussed, followed by an overview of the functions of serotonin, serotonin receptors and their 
pharmacology. Throughout this review comparisons are made with the vertebrate serotonergic system. Last but 
not least, possible applications of pharmacological adjustments of serotonin signaling in insects are discussed. 
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Introduction 
Serotonin (5-hydroxytryptamine or 5-HT) is an ancient 
monoamine neurotransmitter that belongs to the biogenic 
amines. Biogenic amines are derived from aromatic amino 
acids and function as neurotransmitters and neuromodulators 
in the central nervous system or can be released in circulation 
to act as (neuro)hormones. In vertebrates there are five 
established biogenic amine neuromodulators: the indolamine 
5-HT, the imidazolamine histamine and the catecholamines 
dopamine, epinephrine (also called adrenaline) and 
norepinephrine (also called noradrenaline). These biogenic 
amines are often grouped with other small compounds, such 
as acetylcholine, glutamate and gamma-aminobutyric acid, as 
small molecule neurotransmitters. The phenolamines 
tyramine and octopamine are generally considered as the 
protostome analogs of the adrenergic amines in vertebrates 
and other deuterostomes [1-4]. However, octopaminergic 
systems have also been reported in some deuterostomian 
phyla (in species, such as the echinoderm sunflower star 
Psyconopodia helanthoides and the cephalochordate 
Branchiostoma lanceolatum) and monophenolic amines are 
likely to occur in considerable quantities in all triblastic 
animals, except vertebrates [2,5,6]. In vertebrates, octopamine 
and tyramine are present in only very small quantities (trace 
amines) [7].  
Biosynthesis of 5-HT 
Biogenic amines are synthesized starting from amino acids 
by only one or a few enzymatic steps, including a 
decarboxylation. 5-HT belongs to the class of monoamines, 
where a basic amine group is separated from an aromatic 
core by an aliphatic chain with two carbon oxides. The 
synthesis of 5-HT begins with the essential amino acid 
tryptophan. The enzyme tryptophan hydroxylase (TPH), also 
known as tryptophan-5-monooxygenase, first adds a 
hydroxyl group to tryptophan forming 5-hydroxytryptohan 
(5-HTP) [8] (Figure 1). The hydroxylase TPH constitutes 
together with phenylalanine hydroxylase (which catalyzes 
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the hydroxylation of the aromatic side-chain of 
phenylalanine to generate tyrosine) and tyrosine hydroxylase 
(which converts tyrosine to 3,4-dihydroxyphenylalanine or 
DOPA) the non-heme iron and 
tetrahydrobiopterin-dependent aromatic amino acid 
hydroxylase family. These enzymes use 
(6R)-L-erythro-5,6,7,8-tetrahydrobiopterin and O2 as 
cofactors [9,10]. 
In a second step of 5-HT biosynthesis, 5-HTP 
decarboxylase catalyzes the conversion of 5-HTP to 5-HT [11] 
(Figure 1). It has been shown that 5-HTP decarboxylase is 
the same enzyme as dopamine decarboxylase, which 
catalyzes the decarboxylation step in dopamine biosynthesis, 
and is generally called aromatic amino acid decarboxylase 
[12].  
Metabolic pathways of 5-HT 
To act in the nervous system, biogenic amines are stored 
at synaptic terminals for release into the chemical synapse in 
response to neuronal depolarization. In the synaptic cleft, the 
amines bind specific receptor proteins (see § 5.), which can 
be present on both pre- and postsynaptic cells. Synaptic 
effects of the biogenic amines are terminated via re-uptake 
by binding to monoamine transporters [13-15]. These 
transporter proteins belong to a subclass of the 
neurotransmitter/sodium symporter family, a group of 
glycoproteins characterized by their 12 transmembrane 
segments (TM) structure [14,16]. The first identified insect 
amine transporter was the SERotonin Transporter (SERT) 
from the fruit fly Drosophila melanogaster [17,18]. Later, 
insect transporters with high affinity for dopamine [19] and 
tyramine/octopamine [13,20-22] were also identified. In humans, 
these transporters attained much interest because 
psychoactive compounds both for medication and illegal 
drugs interact with them [23].  
After re-uptake, biogenic amines are repacked into 
vesicles for re-release or enzymatically inactivated. In 
vertebrates, the primary catabolic pathway for biogenic 
amines is oxidative deamination by monoamine oxidases [14]. 
Little or no monoamine oxidase activity could be measured 
in insect nervous tissue [24]. Enzymatic inactivation in 
invertebrates is considered to take place after amino-terminal 
tagging with specific groups, mainly N-acetylation or 
N-methylation. However γ-glutamylation, sulphation, and 
β-alanyl conjugation are also possible metabolic routes [25,26].  
Functions of 5-HT in insects 
5-HT is a intracellular signaling molecule found in all 
organisms with a central nervous system. The discovery of 
5-HT as an important neuromodulator involved a 
multidisciplinary approach of several research groups. In the 
1940s, during studies of constricting factors in the blood 
causing hypertension, a serum substance affecting vascular 
tone was isolated and named “serotonin” [27,28]. A chemical 
structure elucidation approach (using ultraviolet absorption 
spectrometry and colorimetric chemical reactions) showed 
that serotonin was 5-hydroxytryptamine (5-HT) [29]. In 1952, 
5-HT was shown to be the same substance as enteramine, a 
compound deduced in the 1930’s from an extract of the 
enterochromaffin cells in gastrointestinal mucosa, which 
caused contraction of the smooth muscle of the rat uterus 
[30,31]. Approximately 80-90% of the human body’s total 
5-HT is located in the enterochromaffin cells of the gut, 
where it is used to regulate intestinal motility [32,33]. A few 
years later, 5-HT was proven to be present in mammalian 
brain, the first step to its recognition as a neuromodulator [34]. 
The observation that the hallucinatory drug lysergide acid 
diethylamide (LSD) antagonized a response produced by 
5-HT further confirmed the idea that 5-HT may be important 
for the behaviour [35].  
Figure 1. Biosynthesis of serotonin (5-HT). Tryptophan is 
converted into 5-hydroxytryptamine (5-HTP) by tryptophan 
hydroxylase (TPH), Next, 5-HTP is converted to 5-HT by 5-HTP 
decarboxylase (also called aromatic amino acid decarboxylase or 
AADC). 
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Nowadays, the role of 5-HT is established in the 
regulation of many important human processes, such as 
appetite, mood and emotion, sleep, sexual activity, pain, and 
learning abilities. In different insect species, comparable 
processes were demonstrated to be affected by 5-HT. For 
example, in D. melanogaster, elevating 5-HT levels, either 
by treatment with 5-HTP or by overexpressing TPH, 
significantly increased periods of sleep [36]. On the contrary, 
entrainment of the Drosophila circadian clock to light was 
inhibited by 5-HT [37]. In several insect species, 5-HT was 
demonstrated to modulate appetite. In D. melanogaster, 
neuromodulatory actions of 5-HT were shown to depress 
feeding, while decreased neuronal 5-HT levels increased 
appetite [38]. In another dipteran species, the flesh fly 
Neobellieria bullata, 5-HT injection in the hemolymph 
decreased feeding [39]. In the honey bee, 5-HT inhibits 
feeding when injected in the brain and excites muscle 
contractions when injected in the gut, although general 
elevation of 5-HT in the bee’s hemolymph did not affect 
food intake [40]. Consistent with these findings, a 5-HT 
receptor was identified as a feeding modulation target from a 
small molecule drug screening in Drosophila [41]. In the 
yellow-fever mosquito Aedes aegypti, 5-HT immunoreactive 
axons surround parts of the salivary gland of adult females 
[42] and the blood-feeding success was reduced by 
administration of the 5-HT depleting drug 
α-methyl-tryptophan [43]. Moreover, 5-HT increased fluid 
secretion from salivary glands in A. aegypti, the fly 
Calliphora vicina and the cockroach Periplaneta americana 
[42,44,45]. In Rhodnius prolixus, 5-HT acts as a diuretic 
hormone. It is produced soon after the initiation of feeding 
and stimulates rapid tubule secretion [46,47]. In Drosophila, 
where insulin-like peptides both regulate blood sugar and act 
as growth factors, serotonergic neurons control the adult 
body size by affecting insulin-like peptide secretion [48,49]. 
How much food an animal gets is not only dependent on the 
abundance of food in the environment but also on the 
animal’s social rank, since the stronger or more dominant 
animals may steal food from the weaker or less dominant 
ones. This may explain why 5-HT is not only engaged in the 
recognition of food availability but also of social rank. 
5-HT also has thorough effects on some aspects of 
learning and memory and is thus a major player in 
modulating several insect behaviors. By inhibiting the 
serotonergic system in neurons of D. melanogaster, 
appetitive olfactory memory performance was considerably 
reduced [50]. Flies with genetically or pharmacologically 
reduced 5-HT levels in the brain also had a strongly reduced 
memory formation in a behavioral test wherein flies were 
trained to avoid a chamber position associated with high 
temperature [51]. In honey bees, both memory storage and 
retrieval were reduced when 5-HT was injected prior to 
conditioning [52-54]. In the desert locust Schistocerca gregaria 
5-HT and its downstream effector molecules were shown to 
induce gregarious, swarming behavior [55,56]. Fruit flies with 
genetically or pharmacologically elevated 5-HT levels 
showed higher fighting frequencies and more intense fighting 
than untreated flies [57]. 
In the periphery, 5-HT seems to affect the performance of 
certain muscles. It was for example shown to have relaxing 
properties on the foregut of the migratory locust Locusta 
migratoria [58], while other experiments demonstrated 
acceleration of the myogenic rhythm of the extensor-tibiae 
muscle in locusts by 5-HT [59]. Also in migratory locusts, 
antidiuretic effects were reported for 5-HT, which may result 
from direct effects on the epithelial and muscular cells of the 
rectum [60].  
5-HT receptors 
5-HT is one of the oldest signaling molecules in evolution, 
which may explain why 5-HT interacts with such a diversity 
of receptors belonging to the G protein-coupled receptor 
(GPCR) and the ligand-gated ion-channel families. The first 
5-HT receptors are estimated to have appeared 700 to 800 
million years ago in single-celled eukaryotes, such as 
paramecia [61-64]. They may indeed have been amongst the 
first rhodopsin-like receptors reacting to a chemical [65]. 
Today, the wealth of 5-HT receptors is generally organized 
in seven classes, termed 5-HT1-7. The major classes, 5-HT1, 
5-HT2, and 5-HT6, possibly evolved from a primordial, 
ancestral 5-HT receptor over 750 million years ago and are 
found in diverse phyla from planarians, nematodes, insects to 
vertebrates, including man [61-63]. The 5-HT5 and 5-HT7 
receptor classes probably deviated from 5-HT1 650 to 700 
million years ago [61,62]. Since these events predate the 
estimated divergence of protostomes and deuterostomes 
about 600 to 650 million years ago [66], the invertebrate and 
vertebrate serotonergic systems are supposed to own roughly 
the same main receptor classes [61,67]. However, further gene 
duplications and structural/functional differentiation led to 
various subtypes within each main class, and these subtypes 
are considered to have evolved independently in 
invertebrates and vertebrates [61,63].  
Insect 5-HT receptors are classified based on sequence 
similarities with their counterparts in vertebrates. Within the 
same receptor class, the signaling properties seem very well 
maintained between insects and vertebrates, but their 
pharmacological characteristics vary significantly. Compared 
to their mammalian (and other vertebrate) counterparts, 
relatively few data about pharmacological properties of 
insect 5-HT receptors are available. 
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Table 1: The vertebrate 5-HT receptor types, their G protein 
coupling characteristics and primary responses. Receptor 
subfamilies with representatives in insects are indicated (•). 
Abbreviations: AC, adenylyl cyclase; PLC, phospholipase C 
Family G-protein Response  
5-HT1 • Gi/o AC inhibition  
5-HT2 • Gq/11 PLC activation 
5-HT3  Ligand-gated ion channel 
5-HT4 Gs AC activation 
5-HT5 Gi/o AC inhibition 
5-HT6 Gs AC activation 
5-HT7 • Gs AC activation 
A recent study provides evidence that agonists of 5-HT 
receptors may constitute potential lead compounds for new 
insecticide discovery [68] (see § 6.2). 
5-HT receptors in vertebrates 
Different classification schemes for 5-HT receptors have 
been used for more than 50 years. Initially, Gaddum and 
Picarelli (1957) [69] described D- and M-type receptors, based 
on pharmacological studies with dibenzyline and morphine. 
In radio-ligand binding studies on brain homogenates of rat, 
Peroutka and Snyder (1979) [70] demonstrated the presence of 
two distinct 5-HT receptor binding sites, named 5-HT1 and 
5-HT2. These data were amalgamated whereby three main 
groups of 5-HT receptors were considered, namely 5-HT1, 
5-HT2 and 5-HT3 (the latter two corresponding to the D and 
M receptors, respectively) [71]. This nomenclature still forms 
the basis for the current classification of 5-HT receptors.  
Presently, vertebrate 5-HT receptors are divided into 
seven main 5-HT receptor families (termed 5-HT1-7) based 
on their gene organization, sequence similarities, 
pharmacological properties and downstream signaling 
pathways [14,64,65,72-74]. Six of these belong to the 
rhodopsin-like family of GPCRs and the lone exception, 
5-HT3, is a cation-selective chloride-channel that belongs to 
the ligand-gated ion-channel superfamily. This receptor is 
composed of five pseudo-symmetrical subunits that surround 
the central ion-channel. Each subunit contains an 
extracellular part with a ligand-binding domain, a TM with 
four α-helices and a cytoplasmatic domain. Activation of the 
receptor, by binding of 5-HT, leads to the opening of the 
channel and a quick inward ion current that will cause a 
depolarization of the plasma membrane [14,65,75]. 5-HT1 and 
5-HT5 couple to Gi/o-proteins, which inhibit adenylyl cyclase 
activity and thus decrease the intracellular cyclic AMP 
(cAMP) levels. 5-HT2 couples to Gq/11-proteins that activate 
phospholipase C (PLC). PLC hydrolyses membrane bound 
phosphoinositides, like phosphatidyl inositol 
4,5-bisphosphate (PIP2). This results in the formation of 
diacylglycerol (DAG) and inositol phosphates like inositol 
1,4,5-trisphosphate (IP3). IP3 causes Ca2+-exemption in the 
cell after binding to ligand-regulated Ca2+-channels on the 
membrane of intracellular Ca2+-storage compartments, such 
as the endoplasmatic reticulum. DAG remains associated to 
the cell membrane where it will activate, together with the 
higher intracellular Ca2+-concentration, Ca2+-dependent 
protein kinase (PKC). PKC phosphorylates serine and 
threonine residues of protein substrates, which alters the 
functional properties of these proteins. 5-HT4, 5HT6 and 
5-HT7 couple to Gs-proteins; the Gαs-subunit stimulates 
adenylyl cyclase activity and hence increases the intracellular 
cAMP levels (Table 1) [14,63-65,73,76]. The main receptor 
families contain different subtypes and isoforms (designated 
a, b, c …). But even this amount of physical diversity 
underscores the physiological relevance of 5-HT. An even 
greater degree of operational diversity can be expected, based 
on the existence of a great number of splice and RNA editing 
variants for several 5-HT receptors (see § 5.1.1). In addition, 
they can be modulated by accessory proteins and chaperones, 
and can form homo- or heteromers both at the GPCR and the 
ligand-gated channel level (for a review, see: Hannon and 
Hoyer, 2008 [65]). 
5-HT receptor multiplicity in vertebrates 
There are five vertebrate 5-HT1 receptor subtypes, all 
encoded by intronless genes: 5-HT1A,B,D,E,F [77-86]. In addition, 
two polymorphisms have been found to alter the extracellular 
amino-terminal region of the human 5-HT1A receptor; one is 
associated with Tourette’s syndrome, and one results in loss 
of response to 5-HT [87,88]. The current 5-HT receptor 
nomenclature does not contain a 5-HT1C receptor. This 
receptor was formerly (incorrectly) classified in the 5-HT1 
receptor family, but was renamed 5-HT2C [74]. This 5-HT2C 
receptor was the first cloned receptor of the 5-HT2 receptor 
family [89,90] which now contains three subtypes: 5-HT2A-C 
[91-94]. The 5-HT2C receptor forms different isoforms through 
RNA editing by adenosine deaminases, which affects agonist 
potency, activation of PLC and selectivity of G protein 
coupling [95-97]. In mammals, a third family of 5-HT GPCRs 
comprises at least nine 5-HT4 isoforms (5-HT4a-g, 5-HT4i and 
5-HT4n) resulting from alternative splicing starting from a 
conserved leucine residue in the intracellular C-terminus. 
Another variant, 5-HT4hb contains a 14 residue insertion in 
the second extracellular loop compared to the 5-HT4b variant 
[98-106]. Moreover, different isoforms that are co-expressed in 
the same tissue were shown to form dimers [107]. Two 
subtypes of 5-HT5 receptors (5-HT5A and 5-HT5B) have been 
cloned in rodents, sharing 70% overall sequence identity 
[108-111]. In humans, the 5-HT5A constitutes the only functional 
5-HT5 receptor. The 5-HT5B receptor gene has been mapped 
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to the human genome, but does not encode a functional 
protein [112,113]. The first functional 5-HT6 receptor was 
cloned from rat cDNA starting from the sequence of the rat 
histamine H2 receptor [114]. The rat sequence was later 
corrected, together with cloning of the human 5-HT6 receptor 
sequence [115]. A degenerate PCR approach on human cDNA 
was used to identify a nonfunctioinal 5-HT6 receptor splice 
variant [116]. Members of the 5-HT7 receptor family were 
cloned around the same time from rodent and human. Two 
introns are found in the mammalian receptor encoding gene, 
from which one is alternatively spliced resulting in 
differences in the intracellular C-terminus [117-125]. In rat and 
mouse tissue, three 5-HT7 isoforms were found, called 
5-HT7a, 5-HT7b and 5-HT7c. Two human splice variants 
correspond to isoforms a and b, but a third constitutes a 
distinct isoform, called 5-HT7d [118,119,126,127]. 
5-HT receptors in insects 
For many years, the work on 5-HT receptors of 
invertebrate physiologists and pharmacologists has paralleled 
that of vertebrate researchers. This resulted in a distinct 
nomenclature for invertebrate 5-HT receptors that became 
increasingly confusing when compared to the vertebrate 
classification. Tierney (2001) [63] proposed a classification 
system for invertebrate 5-HT receptors based on the 
vertebrate nomenclature, considering the common ancestry 
of insect and vertebrate 5-HT receptors. Indeed, as 
mentioned above, the main receptor classes are believed to 
have diverged from a primordial 5-HT receptor before the 
estimated separation of protostomes and deuterostomes 
[61,62,66].  
Based on the conserved amino acid sequences and 
activated second-messenger systems, insect 5-HT receptors 
can be classified as 5-HT1, 5-HT2 and 5-HT7 type GPCRs. D. 
melanogaster was the first insect species in which four 
different 5-HT receptors were pharmacologically 
characterized, namely a 5-HT1α/A, 5-HT1β/B, 5-HT2α/A and 
5-HT7 receptor [128,129]. In addition, the existence of a second 
5-HT2 receptor (5-HT2β/B) was suggested and recently 
confirmed experimentally [41,130,131]. In the field cricket, 
partial sequences of two 5-HT1, two 5-HT2 and a 5-HT7 
receptor were identified as well [132,133]. Two 5-HT1 receptors 
were also predicted in the genome of T. castaneum, one of 
these was characterized [134,135] and two 5-HT1 splice variants 
were described in Papilio xuthus [136]. On the contrary, in the 
locust L. migratoria only one 5-HT1 receptor was partially 
cloned and also in A. mellifera and P. americana only one 
5-HT1 receptor was characterized thus far [137-139]. As in D. 
melanogaster and G. bimaculatus, two 5HT2 receptors were 
identified from A. mellifera [41,128,130-133,140], while in other 
insects, such as T. castaneum and the locust L. migratoria, 
only one 5-HT2 receptor has been found thus far [134,137]. 
Lastly, ever since the first insect 5-HT7 receptor was 
identified from a Drosophila genomic and a cDNA library 
[129,141], (partial) cDNA sequences of 5-HT7 receptors from 
other insects were cloned and some of these were 
functionally characterized [133,134,137,142,143]. Based on the data 
from characterized insect 5-HT receptors, most insects seem 
to possess one 5-HT7 type serotonin receptor, but may 
possess two 5-HT1 and/or two 5-HT2 receptors. 
Similarly to vertebrate receptors, alternative splicing 
seems a general mechanism for creating extra multiplicity in 
the insect 5-HT receptor system (for example the 5-HT1 
receptors of D. melanogaster and P. xuthus) [129,136]. 
Insect 5-HT receptors often show high expression in 
nervous tissue (e.g. brain and ventral nerve cord) 
[36,37,133,135,138,142-144]. High 5-HT1 protein levels in the central 
nervous system were associated with involvement in visual 
information processing in honey bee foragers [138] and 
possible roles in neuroendocrine secretion processes and 
motility of the gut in cockroaches [139]. The expression of 
5-HT7 in different parts of the honey bee brain suggested a 
role for the receptor in neural pathways for information 
processing, learning and memory [142]. Several insect 5-HT7 
receptors were also found to be highly expressed in the 
salivary gland (FlyAtlas, http://www/flyatlas.cor/) [133,145] and 
suggested to be involved in 5-HT induced saliva secretion, 
which was shown to be mediated via an increase in 
intracellular cAMP in several insect species [44,45,139,146-149]. 
Immunohistochemistry with antibodies against the A. aegypti 
5-HT7 receptor labeled two axons that run in parallel along 
the hindgut [144]. In L. migratoria, high serotonergic 
immunoreactivity was measured in the midgut and 
application of 5-HT induced relaxation of the midgut circular 
muscle [150]. 5-HT7 receptor-mediated regulation of visceral 
muscle activity in the gastrointestinal tract may be 
evolutionary conserved between invertebrates and 
vertebrates, since also mammalian 5-HT7 receptors were 
demonstrated to mediate smooth muscle relaxation of the 
gastrointestinal tract [151].  
Pharmacology of vertebrate 5-HT receptors 
The pharmacology of mammalian 5-HT receptor subtypes 
has been extensively studied (http://www.iuphar-db.org). We 
will only briefly discuss a selection of agonists and 
antagonists, focusing on 5-HT1, 5-HT2 and 5-HT7 receptors, 
since orthologs of these receptor types were found in insects. 
5-HT1A receptors are probably the most extensively 
examined receptor group. One of the first major full and 
selective 5-HT1A receptor agonists to be discovered was  
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Table 2. Overview of pharmacological agents tested on insect serotonin receptors 
Receptor Transduction Agonists EC50 Antagonists Cells References 
Drome 5-HT1A decrease cAMP 5-HT  dihydroergocryptine Cos-7 Saudou et al., 1992[129] 
CAA77570 increase IP 8-OH-DPAT  prazosin   
    d-butaclamol   
    methysergide   
    l-butaclamol   
    yohimbine   
  5-HT 1 µM methiothepin HEK293T Gasque et al., 2013[41] 
Drome 5-HT1B decrease cAMP 5-HT  dihydroergocryptine Cos-7 Saudou et al., 1992[129] 
CAA77571 increase IP 8-OH-DPAT  d-butaclamol   
    prazosin   
    methysergide   
    yohimbine   
    l-butaclamol   
  5-HT 625 nM methiothepin HEK293T Gasque et al., 2013[41] 
Apime 5-HT1A decrease cAMP 5-HT 16.9 nM methiothepin HEK293 Thamm et al., 2010[138] 
CBI75449  5-CT 700.5 nM prazosin (partial)   
  5-MT 3.63 µM WAY-100635 (partial)   
Trica 5-HT1  5-HT 95 nM prazosin CHO-WTA11 Vleugels et al., 2013[135] 
KC196076  α-Me5-HT 10.7 µM methiothepin   
  5-CT 24.7 µM methysergide   
  5-MT 91.8 µM d-butaclamol   
  8-OH-DPAT 551.0 µM SB-269970   
    WAY-100635   
    ketanserin (NR)   
    mianserin (NR)   
    yohimbine (NR)   
 decrease cAMP 5-HT 82.7 nM  HEK293 Vleugels et al., 2013[135] 
Peram 5-HT1 decrease cAMP 5-HT 130 nM WAY-100635 (inverse) HEK293 Troppmann et al., 2010[139] 
FN298392  5-MT (partial) Methiothepin (neutral)   
Drome 5-HT2(A) ? 5-HT  ritanserin Cos-1 Colas et al., 1995[128] 
CAA57429  N-acetyl-5-HT  ketanserin   
  α-Me5-HT  pizotifen   
  2-Me5-HT  setoperone   
  tryptamine  spiperone   
  1-Me5-HT  cyproheptadine   
  5-MT  TFMPP   
   quipazine  mesulergine   
  5-MT  methysergide   
  8-OH-DPAT  methiothepine   
  5-CT  rauwolscine   
    buspirone   
    yohimbine   
    bufotenine   
    sulpiride   
    mianserin   
    clozapine   
    cis-flupenthixol   
    haloperidol   
  5-HT 99 nM methiothepin HEK293T Gasque et al., 2013[41] 
Drome 5-HT2B  5-HT 293 nM methiothepin HEK293T Gasque et al., 2013[41] 
CG42796       
Apime 5-HT2A increase Ca2+ 5-HT 25.7 nM SB-269970 HEK293 Thamm et al., 2013[140] 
FR727107  5-MT 70 nM mianserin   
  8-OH-DPAT 55.9 µM cyproheptadine   
    methiothepin   
    clozapine   
    methysergide   
Apime 5-HT2B increase Ca2+ 5-HT 32.5 nM cyproheptadine HEK293 Thamm et al., 2013[140] 
FR727108  5-MT 60.4 nM ketanserin   
  8-OH-DPAT 561.5 nM mianserin   
    clozapine   
Drome 5-HT7 increase cAMP 5-HT 60 nM dihydroergocryptine NIH 3T3 Witz et al., 1990[141] 
M55533  2-Me5HT 0.6 µM d-butaclamol   
  5-MT 0.8 µM methysergide   
  d-LSD 1.5 µM    
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  8-OH-DPAT NR    
 increase cAMP 5-HT  dihydroergocryptine Cos-7 Saudou et al., 1992[129] 
  8-OH-DPAT  d-butaclamol   
    methysergide   
    prazosin   
    l-butaclamol   
    yohimbine   
  5-HT 12 nM metitepine HEK293T Gasque et al., 2013[41] 
Apime5-HT7 increase cAMP 5-HT 1.1-1.8 nM methiothepin (inverse) HEK293 Schlenstedt et al., 2006[142] 
CAJ28210  5-CT 24-40 nM SB-269970 (poor)   
    clozapine (NR)   
  AS-19 moderate    
  8-OH-DPAT poor    
Trica 5-HT7  5-HT 27.3 nM ketanserin CHO-WTA11 Vleugels et al., 2014[143] 
XP_966577  α-Me5-HT 5.2 µM methysergide   
  5-CT 22.2 µM methiothepine   
  5-MT 30.3 µM d-butaclamol   
  8-OH-DPAT 38.8 µM prazosin   
    SB-269970   
    yohimbine   
    WAY-100635   
    mianserin   
 increase cAMP 5-HT 6.6 nM  HEK293 Vleugels et al., 2014[143] 
Aedae5-HT7 increase cAMP 5-HT 39.5 nM  CHO-K1 Lee and Pietrantonio, 2003[169] 
AAG49292  5-CT moderate    
  8-OH-DPAT moderate    
  pimozide poor    
Pharmacological profiles of heterologously expressed insect 5-HT receptors. Agonists and antagonists are shown according to decreasing 
potency (per receptor and cell type). Agonists and antagonists that exhibited no response (NR) are shown in grey and italic. Abbreviations 
used: 5-CT, 5-carboxamidotryptamine; 5-HT, 5-hydroxytryptamine; 5-MT, 5-methoxytryptamine; 8-OH-DPAT, 
8-hydroxy-2-(di-n-propylamino)tetralin; Aedae, Aedes aegypti; Apime, Apis mellifera; AS-19, 
(2S)-N,N-dimethyl-5-(1,3,5-trimethylpyrazol-4-yl)-1,2,3,4-tetrahydronaphthalen-2-amine; cAMP, cyclic adenosine monophosphate; CHO, 
Chinese hamster ovary; Cos, fibroblast-like cell line derived from monkey kidney tissue; Drome, Drosophila melanogaster; EC50, half maximal 
effective concentration; HEK, human embryonic kidney; IP, inositol phosphate; Me5-HT, methyl hydroxytryptamine; NIH, fibroblast cell line 
derived from mouse embryos; Peram, Periplaneta americana; SB-269970, 2R)-1-[(3-hydroxyphenyl)sulfonyl]-2 
-(2-(4-methyl-1-piperidinyl)ethyl)pyrrolidine; Trica, Tribolium castaneum; WAY-100635, N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]- 
N-(2-pyridyl)cyclohexanecarboxamide. 
8-OH-DPAT (8-hydroxy-2-(di-n-propylamino)tetralin) 
[84,152]. It was later shown to have some minor affinity for 
5-HT1D and 5-HT7 receptors as well (see IUPHAR database 
and references therein). Another well-known agonist of 
5-HT1 and 5-HT7 receptors is 5-CT 
(5-carboxyamidotryptamine) [117,153,154]. Agonists with minor 
affinity for 5-HT1 receptors are 5-MeOT 
(5-methoxytryptamine) which has high agonistic activity on 
5-HT2A and 5-HT7 receptors, and αm-5-HT 
(α-methylserotonin) which has higher specificity for 5-HT2 
receptors compared to all other 5-HT receptor (sub)types 
[117,153,155-157]. Antagonists with very high specificity were 
found for some mammalian 5-HT receptors. The piperazine 
drug WAY-100635 is a potent antagonist of 5-HT1A 
receptors [158,159], while SB-269970 is a potent antagonist of 
5-HT7 receptors [160,161]. However, WAY-100635 was also 
shown to be a D4 dopamine receptor agonist [162] and 
SB-269970 was able to block α2-adrenoceptors to some 
extent [163]. Several potent 5-HT2 receptor antagonists with 
only minor binding affinity for other 5-HT receptors are 
known, including mianserin, ketanserin, and butaclamol (see 
IUPHAR database and references therein). However, all have 
affinity for other biogenic amine receptors as well, with a 
particularly high binding affinity of ketanserin for 
α1-adrenergic receptors [164] and of butaclamol for dopamine 
receptors [165-168]. Several non-selective 5-HT receptor 
antagonists were characterized, such as methiothepin and 
methysergide. 
Pharmacology of insect 5-HT receptors 
Despite the sequence and signaling similarities, the 
pharmacology of insect 5-HT receptors is curiously different 
from that of their vertebrate counterparts. The long 
evolutionary history of the 5-HT signaling systems after the 
divergence of protostomes and deuterostomes, allowed for 
further differentiation into subtypes independently in insects 
and vertebrates [63,64]. During this evolution, selection was 
likely based on functionally important receptor 
characteristics, such as ligand binding and G protein 
coupling, and not the conservation of recognition sites for 
man-made, synthetic ligands [143].  
Although the pharmacology of the mammalian receptors is 
thoroughly studied (and drugs affecting biogenic amine 
receptor binding are among the most important in the armory 
of modern pharmacology), the specificity of these drugs 
towards insect receptors has never been comprehensively 
tested and profound characterization studies of insect 5-HT 
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receptors are scarce. Consequently much less is known about 
the pharmacology of these receptors. However, it is a 
recurring fact that the synthetic agonists, designed for 
vertebrate receptors, are much less potent and often also less 
efficient than the natural ligand 5-HT on insect 5-HT 
receptors. For example, the mammalian 5-HT1/7 receptor 
agonists, 8-OH-DPAT and 5-CT, act only as poor agonists 
on insect 5-HT1/7 receptors [135,138,139,142,143,169]. Little 
information is also available about selective or potent 
antagonists of insect 5-HT receptors and only limited 
similarity is observed with the mammalian receptor 
pharmacology (Table 2). The potent and selective 
mammalian 5-HT1A antagonist WAY-100635 showed only 
minor antagonistic activity on insect 5-HT1 receptors, i.e. 
from A. mellifera, P. americana and T. castaneum [135,138,139]. 
The mammalian 5-HT7 receptor antagonist SB-269970 has 
been shown to be a potent antagonist of the 5-HT7 receptor 
from C. vicina, but had only poor influence on activity of the 
5-HT7 receptors from A. mellifera and T. castaneum 
[142,143,145]. The non-selective 5-HT antagonists of vertebrate 
5-HT receptors, methysergide and methiothepin, were also 
able to decrease insect 5-HT receptor activity [135,143]. 
5-HT receptors as pharmacological targets 
5-HT receptors as drug targets 
Depression and anxiety disorders are two well-known 
health problems for which compounds that influence 5-HT 
receptor activity are prescribed. About 80% of all 
antidepressants on the market are selective serotonin 
re-uptake inhibitors (SSRIs), preventing 5-HT uptake from 
the synapse by SERTs. A main disadvantage of SSRIs is that 
the onset of their therapeutic action requires weeks of 
treatment. The use of partial agonists of 5-HT1A receptors 
and inhibitors of 5-HT2A receptors was shown to accelerate 
clinical antidepressant effects [23,170-173]. Recently, two new 
antidepressant drugs (vilazodone and vortioxetine) which 
combine partial 5-HT1A agonist properties with SERT 
blockade are approved by the FDA (U.S. Food and Drug 
Administration) to treat depression (Reuters Press Release, 
2011; U.S. Food and Drug Administration Press Release, 
2013). Partial 5-HT1 agonists, including certain azapirones, 
are also used as anxiolytic drugs [172,174]. It is very likely that 
5-HT4 receptor partial agonists could behave as rapid and 
effective antidepressants as well [175]. 
The most widely used anti-migraine drugs are triptans 
which bind with high affinity to 5-HT1B/D/F receptors. 
However, 5-HT1F is the most attractive target for new 
anti-migraine drugs since activation of 5-HT1B induces 
cardiac adverse effects and 5-HT1D agonists – although 
effective in animal models of migraine – failed to properly 
attenuate migraine attacks in clinical trials. One selective 
5-HT1F agonist (lasmiditan) has successfully completed 
phase 2 clinical trials (in 2007 for an intravenous and in 2010 
for an oral application) [176]. Also agonists of other 5-HT 
receptors are used in treatment of various health problems 
(for example [177,178]). 
5-HT receptors as potential insecticide targets 
The poor affinity and selectivity on insect receptors of the 
synthetic compounds that were originally designed for 
mammalian receptor subtypes indicate the importance to 
look for pharmacological agents that target the insect 
receptor types more specifically, both for research and insect 
control. Indeed, although 5-HT receptors are involved in 
many key processes of insect life, no insecticides that target 
this receptor group are available at this moment. However, 
one study provided evidence that 5-HT receptor agonists may 
form potential lead compounds for new insecticide discovery 
[68]. They used the 5-HT1A agonist PAPP 
(1-[(4-aminophenyl)ethyl]-4-[3-(trifluoromethyl)phenyl]pipe
razine) as a lead compound for new insecticides with novel 
mode of action. The PAPP scaffold was used to design and 
synthesize a series of compounds that were evaluated for 
biological activity against the lepidopteran armyworm 
Pseudaletia separata. Most of the compounds indeed 
displayed growth-inhibiting potential or induced larval death. 
Another study in Drosophila shows that the general 5-HT 
receptor antagonist methiothepin inhibits feeding through 
5-HT2A [41]. Given the ubiquity of 5-HT signaling in the 
animal kingdom, any insect control agent targeting 5-HT 
receptors would have to be thoroughly tested for specificity 
to avoid toxicity on a wide range of species [55,179]. 
Concluding remarks 
Several interesting studies have highlighted the 
omnipresent and overwhelming functions of serotonin both 
in vertebrates as in invertebrates. The number of studies on 
the role of serotonin in insects is still relatively limited, but 
these studies already underline the immense importance of 
serotonin signaling in nearly all major physiological 
processes in insects.  
Identification and classification of insect 5-HT receptors is 
merely based on sequence similarity with mammalian 
receptors. Although this information can provide indications 
for receptor classification and comparison, it does not allow 
for accurate predictions of the pharmacological 
characteristics of these receptors. The current 
pharmacological data available on insect 5-HT receptors 
suggest that it should be possible to find selective synthetic 
ligands for specific insect 5-HT receptors. However, a lot of 
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additional research, contributing both to proper insect 5-HT 
receptor classification and to understanding their in vivo 
functionality, will be necessary before a selective insecticide 
can be developed. 
Acknowledgements 
RV was supported by a PhD fellowship from IWT 
(Agency for Innovation by Science and Technology in 
Flanders). HV was supported by the Research Foundation of 
Flanders (FWO Flanders). Our research is also sponsored by 
the Interuniversity Attraction Poles program (Belgian 
Science Policy Grant P7/40) and the KU Leuven Research 
Foundation (GOA/11/02). 
Authors’ contributions: RV and HV contributed equally 
to the manuscript; JV is the senior academic author and 
revised the manuscript critically. 
List of abbreviations 
5-CT:5-carboxamidotryptamine; 5-HT: 
5-hydroxytryptamine or serotonin; 5-HTTP: 
5-hydroxytryptohan; 5-MeOT: 5-methoxytryptamine; 8-OH- 
DPAT: 8-hydroxy-2-(di-n-propylamino) tetralin; αM-5-HT: 
α-methylserotonin; GPCR: G protein-coupled receptor; IP3: 
inositol 1,4,5-trisphosphate; DAG: diacylglycerol; DOPA: 
3,4-dihydroxyphenylalanine; LSD: lysergide acid 
diethylamide; PAPP: 1-[(4-aminophenyl)ethyl]-4- 
[3-(trifluoromethyl)phenyl]piperazine; PKC: Ca2+-dependent 
protein kinase; PLC: phospholipase C; PIP2: phosphatidyl 
inositol 4,5-bisphosphate; SERT: SERotonin Transporter; 
SSRI: selective serotonin re-uptake inhibitor; TM: 
transmembrane segments; TPH: tryptophan hydroxylase. 
References 
1. Blenau W, Baumann A. Molecular and pharmacological properties 
of insect biogenic amine receptors: lessons from Drosophila 
melanogaster and Apis mellifera. Arch Insect Biochem Physiol 
2001; 48:13-38. 
2. Pflüger HJ, Stevenson PA. Evolutionary aspects of 
octopaminergic systems with emphasis on arthropods. Arthropod 
Struct Dev 2005; 34:379-396. 
3. Robertson HA, Juorio AV. Octopamine and some related 
noncatecholic amines in invertebrate nervous systems. Int Rev 
Neurobiol 1976; 19:173-224. 
4. Roeder T, Degen J, Dyczkowski C, Gewecke M. Pharmacology 
and molecular biology of octopamine receptors from different 
insect species. Prog Brain Res 1995; 106:249-258. 
5. Juorio AV, Robertson HA. Identification and distribution of some 
monoamines in tissues of the sunflower star, Pycnopodia 
helianthoides (Echinodermata). J Neurochem 1977; 28:573-579. 
6. Moret F, Guilland JC, Coudouel S, Rochette L, Vernier P. 
Distribution of tyrosine hydroxylase, dopamine, and serotonin in 
the central nervous system of amphioxus (Branchiostoma 
lanceolatum): implications for the evolution of catecholamine 
systems in vertebrates. J Comp Neurol 2004; 468:135-150. 
7. Premont RT, Gainetdinov RR, Caron MG. Following the trace of 
elusive amines. Proc Natl Acad Sci U S A 2001; 98:9474-9475. 
8. Roberts KM, Fitzpatrick PF. Mechanisms of tryptophan and 
tyrosine hydroxylase. IUBMB Life 2013; 65:350-357. 
9. Fitzpatrick PF. Tetrahydropterin-dependent amino acid 
hydroxylases. Annu Rev Biochem 1999; 68:355-381. 
10. Hufton SE, Jennings IG, Cotton RG. Structure and function of the 
aromatic amino acid hydroxylases. Biochem J 1995; 311:353-366. 
11. Kim-Ha J, Smith JL, Macdonald PM. oskar mRNA is localized to 
the posterior pole of the Drosophila oocyte. Cell 1991; 66:23-35. 
12. Lovenberg W, Weissbach H, Udenfriend S. Aromatic L-amino 
acid decarboxylase. J Biol Chem 1962; 237:89-93. 
13. Donly BC, Caveney S. A transporter for phenolamine uptake in 
the arthropod CNS. Arch Insect Biochem Physiol 2005; 
59:172-183. 
14. Nichols DE, Nichols CD. Serotonin receptors. Chem Rev 2008; 
108:1614-1641. 
15. Scavone C, McKee M, Nathanson JA. Monoamine uptake in 
insect synaptosomal preparations. Insect Biochem Mol Biol 1994; 
24:589-597. 
16. Torres GE, Carneiro A, Seamans K, Fiorentini C, Sweeney A, Yao 
WD, et al. Oligomerization and trafficking of the human 
dopamine transporter. Mutational analysis identifies critical 
domains important for the functional expression of the transporter. 
J Biol Chem 2003; 278:2731-2739. 
17. Corey JL, Quick MW, Davidson N, Lester HA, Guastella J. A 
cocaine-sensitive Drosophila serotonin transporter: cloning, 
expression, and electrophysiological characterization. Proc Natl 
Acad Sci U S A 1994; 91:1188-1192. 
18. Demchyshyn LL, Pristupa ZB, Sugamori KS, Barker EL, Blakely 
RD, Wolfgang WJ, et al. Cloning, expression, and localization of 
a chloride-facilitated, cocaine-sensitive serotonin transporter from 
Drosophila melanogaster. Proc Natl Acad Sci U S A 1994; 
91:5158-5162. 
19. Porzgen P, Park SK, Hirsh J, Sonders MS, Amara SG. The 
antidepressant-sensitive dopamine transporter in Drosophila 
melanogaster: a primordial carrier for catecholamines. Mol 
Pharmacol 2001; 59:83-95. 
20. Malutan T, McLean H, Caveney S, Donly C. A high-affinity 
octopamine transporter cloned from the central nervous system of 
cabbage looper Trichoplusia ni. Insect Biochem Mol Biol 2002; 
32:343-357. 
21. Nathanson JA, Hunnicutt EJ, Kantham L, Scavone C. Cocaine as a 
naturally occurring insecticide. Proc Natl Acad Sci U S A 1993; 
90:9645-9648. 
22. Roeder T, Gewecke M. Octopamine uptake systems in thoracic 
ganglia and leg muscles of Locusta migratoria. Comp Biochem 
Physiol 1989; 94:143-147. 
23. Jones BJ, Blackburn TP. The medical benefit of 5-HT research. 
Pharmacol Biochem Behav 2002; 71:555-568. 
24. Dewhurst SA, Croker SG, Ikeda K, McCaman RE. Metabolism of 
Neurotransmitter 2015; 2: e314. doi: 10.14800/nt.314; © 2015 by Rut Vleugels, et al. 
http://www.smartscitech.com/index.php/nt 
 
Page 10 of 14 
 
biogenic amines in Drosophila nervous tissue. Comp Biochem 
Physiol B 1972; 43:975-981. 
25. Fickbohm DJ, Spitzer N, Katz PS. Pharmacological manipulation 
of serotonin levels in the nervous system of the opisthobranch 
mollusc Tritonia diomedea. Biol Bull 2005; 209:67-74. 
26. Sloley BD. Metabolism of monoamines in invertebrates: the 
relative importance of monoamine oxidase in different phyla. 
Neurotoxicology 2004; 25:175-183. 
27. Rapport MM, Green AA, Page IH. Serum vasoconstrictor, 
serotonin; isolation and characterization. J Biol Chem 1948; 
176:1243-1251. 
28. Rapport MM, Green AA, Page IH. Crystalline serotonin. Science 
1948; 108:329-330. 
29. Rapport MM. Serum vasoconstrictor (serotonin) the presence of 
creatinine in the complex; a proposed structure of the 
vasoconstrictor principle. J Biol Chem 1949; 180:961-969. 
30. Erspamer V, Asero B. Identification of enteramine, the specific 
hormone of the enterochromaffin cell system, as 
5-hydroxytryptamine. Nature 1952; 169:800-801. 
31. Vialli M, Erspamer V. Ricerche sul secreto delle cellule 
enterocromaffini. Zellforschung mikr Anatomie 1937; 27:81-99. 
32. Berger M, Gray JA, Roth BL. The expanded biology of serotonin. 
Annu Rev Med 2009; 60:355-366. 
33. Gershon MD, Tack J. The serotonin signaling system: From basic 
understanding to drug development-for functional GI disorders. 
Gastroenterology 2007; 132:397-414. 
34. Twarog BM, Page IH. Serotonin content of some mammalian 
tissues and urine and a method for its determination. Am J Physiol 
1953; 175:157-161. 
35. Woolley DW, Shaw E. Some neurophysiological aspects of 
serotonin. Br Med J 1954; 2:122-126. 
36. Yuan Q, Joiner WJ, Sehgal A. A sleep-promoting role for the 
Drosophila serotonin receptor 1A. Curr Biol 2006; 16:1051-1062. 
37. Yuan Q, Lin F, Zheng X, Sehgal A. Serotonin modulates circadian 
entrainment in Drosophila. Neuron 2005; 47:115-127. 
38. Neckameyer WS. A trophic role for serotonin in the development 
of a simple feeding circuit. Dev Neurosci 2010; 32:217-237. 
39. Dacks AM, Nickel T, Mitchell BK. An examination of serotonin 
and feeding in the flesh fly Neobellieria bullata (Sarcophagidae: 
Diptera). J Insect Behav 2003; 16:1-21. 
40. French AS, Simcock KL, Rolke D, Gartside SE, Blenau W, 
Wright GA. The role of serotonin in feeding and gut contractions 
in the honeybee. J Insect Physiol 2014; 61:8-15. 
41. Gasque G, Conway S, Huang J, Rao Y, Vosshall LB. Small 
molecule drug screening in Drosophila identifies the 5HT2A 
receptor as a feeding modulation target. Sci Rep 2013; 
3:srep02120. 
42. Novak MG, Ribeiro JMC, Hildebrand JG. 5-Hydroxytryptamine 
in the salivary-glands of adult female Aedes aegypti and its role in 
regulation of salivation. J Exp Biol 1995; 198:167-174. 
43. Novak MG, Rowley WA. Serotonin depletion affects 
blood-feeding but not host-seeking ability in Aedes triseriatus 
(Diptera: Culicidae). J Med Entomol 1994; 31:600-606. 
44. Berridge MJ, Patel NG. Insect salivary glands - Stimulation of 
fluid secretion by 5-hydroxytryptamine and 
adenosine-3',5'-monophosphate. Science 1968; 162:462-463. 
45. Walz B, Baumann O, Krach C, Baumann A, Blenau W. The 
aminergic control of cockroach salivary glands. Arch Insect 
Biochem Physiol 2006; 62:141-152. 
46. Donini A, O'Donnell MJ, Orchard I. Differential actions of 
diuretic factors on the Malpighian tubules of Rhodnius prolixus. J 
Exp Biol 2008; 211:42-48. 
47. Maddrell SH, Herman WS, Mooney RL, Overton JA. 
5-Hydroxytryptamine: a second diuretic hormone in Rhodnius 
prolixus. J Exp Biol 1991; 156:557-566. 
48. Kaplan DD, Zimmermann G, Suyama K, Meyer T, Scott MP. A 
nucleostemin family GTPase, NS3, acts in serotonergic neurons to 
regulate insulin signaling and control body size. Genes Dev 2008; 
22:1877-1893. 
49. Ruaud AF, Thummel CS. Serotonin and insulin signaling team up 
to control growth in Drosophila. Genes Dev 2008; 22:1851-1855. 
50. Sitaraman D, Laferriere H, Birman S, Zars T. Serotonin is critical 
for rewarded olfactory short-term memory in Drosophila. J 
Neurogenet 2012; 26:238-244. 
51. Sitaraman D, Zars M, Laferriere H, Chen YC, Sable-Smith A, 
Kitamoto T, et al. Serotonin is necessary for place memory in 
Drosophila. Proc Natl Acad Sci U S A 2008; 105:5579-5584. 
52. Bicker G, Menzel R. Chemical codes for the control of behaviour 
in arthropods. Nature 1989; 337:33-39. 
53. Menzel R, Heyne A, Kinzel C, Gerber B, Fiala A. 
Pharmacological dissociation between the reinforcing, sensitizing, 
and response-releasing functions of reward in honeybee classical 
conditioning. Behav Neurosci 1999; 113:744-754. 
54. Mercer AR, Menzel R. The effects of biogenic amines on 
conditioned and unconditioned responses to olfactory stimuli in 
the honeybee Apis mellifera. J Comp Physiol A 1982; 
145:363-368. 
55. Anstey ML, Rogers SM, Ott SR, Burrows M, Simpson SJ. 
Serotonin mediates behavioral gregarization underlying swarm 
formation in desert locusts. Science 2009; 323:627-630. 
56. Ott SR, Verlinden H, Rogers SM, Brighton CH, Quah PS, 
Vleugels RK, et al. Critical role for protein kinase A in the 
acquisition of gregarious behavior in the desert locust. Proc Natl 
Acad Sci U S A 2012; 109:E381-E387. 
57. Dierick HA, Greenspan RJ. Serotonin and neuropeptide F have 
opposite modulatory effects on fly aggression. Nat Genet 2007; 
39:678-682. 
58. Wood SJ, Osborne RH, Cattell KJ, Banner SE. FMRFamide and 
related peptides modulate the actions of 5-hydroxytryptamine and 
proctolin on the foregut of the locust, Schistocerca gregaria. 
Biochem Soc Trans 1990; 18:384-385. 
59. Evans PD, Myers CM. Peptidergic and aminergic modulation of 
insect skeletal muscle. J Exp Biol 1986; 124:143-176. 
60. Fournier B, Guerineau N, Mollard P, Girardie J. Effects of two 
neuronal antidiuretic molecules, neuroparsin and 
5-hydroxytryptamine, on cytosolic free calcium monitored with 
indo-1 in epithelial and muscular cells of the African locust 
rectum. Biochim Biophys Acta 1994; 1220:181-187. 
Neurotransmitter 2015; 2: e314. doi: 10.14800/nt.314; © 2015 by Rut Vleugels, et al. 
http://www.smartscitech.com/index.php/nt 
 
Page 11 of 14 
 
61. Peroutka SJ, Howell TA. The molecular evolution of G 
protein-coupled receptors: focus on 5-hydroxytryptamine 
receptors. Neuropharmacology 1994; 33:319-324. 
62. Walker RJ, Brooks HL, Holden-Dye L. Evolution and overview of 
classical transmitter molecules and their receptors. Parasitology 
1996; 113 Suppl:S3-33. 
63. Tierney AJ. Structure and function of invertebrate 5-HT receptors: 
a review. Comp Biochem Physiol A 2001; 128:791-804. 
64. Hoyer D, Hannon JP, Martin GR. Molecular, pharmacological and 
functional diversity of 5-HT receptors. Pharmacol Biochem Behav 
2002; 71:533-554. 
65. Hannon J, Hoyer D. Molecular biology of 5-HT receptors. Behav 
Brain Res 2008; 195:198-213. 
66. Ayala FJ, Rzhetsky A, Ayala FJ. Origin of the metazoan phyla: 
Molecular clocks confirm paleontological estimates. Proc Natl 
Acad Sci U S A 1998; 95:606-611. 
67. Hauser F, Cazzamali G, Williamson M, Blenau W, 
Grimmelikhuijzen CJP. A review of neurohormone GPCRs 
present in the fruitfly Drosophila melanogaster and the honey bee 
Apis mellifera. Progr Neurobiol 2006; 80:1-19. 
68. Cai M, Li Z, Fan F, Huang Q, Shao X, Song G. Design and 
synthesis of novel insecticides based on the serotonergic ligand 
1-[(4-aminophenyl)ethyl]-4-[3-(trifluoromethyl)phenyl]piperazine 
(PAPP). J Agric Food Chem 2010; 58:2624-2629. 
69. Gaddum JH, Picarelli ZP. Two kinds of tryptamine receptor. Br J 
Pharmacol Chemother 1957; 12:323-328. 
70. Peroutka SJ, Snyder SH. Multiple serotonin receptors: differential 
binding of [3H]5-hydroxytryptamine, [3H]lysergic acid 
diethylamide and [3H]spiroperidol. Mol Pharmacol 1979; 
16:687-699. 
71. Bradley PB, Engel G, Feniuk W, Fozard JR, Humphrey PP, 
Middlemiss DN, et al. Proposals for the classification and 
nomenclature of functional receptors for 5-hydroxytryptamine. 
Neuropharmacology 1986; 25:563-576. 
72. Gerhardt CC, Van Heerikhuizen H. Functional characteristics of 
heterologously expressed 5-HT receptors. Eur J Pharmacol 1997; 
334:1-23. 
73. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, 
Mylecharane EJ, et al. International union of pharmacology 
classification of receptors for 5-hydroxytryptamine (serotonin). 
Pharmacol Rev 1994; 46:157-203. 
74. Humphrey PP, Hartig P, Hoyer D. A proposed new nomenclature 
for 5-HT receptors. Trends Pharmacol Sci 1993; 14:233-236. 
75. Hoyer D. Serotonin 5-HT3, 5-HT4, and 5-HT-M receptors. 
Neuropsychopharmacology 1990; 3:371-383. 
76. Scheiner R, Baumann A, Blenau W. Aminergic control and 
modulation of honeybee behaviour. Curr Neuropharmacol 2006; 
4:259-276. 
77. Adham N, Ellerbrock B, Hartig P, Weinshank RL, Branchek T. 
Receptor reserve masks partial agonist activity of drugs in a 
cloned rat 5-hydroxytryptamine1B receptor expression system. 
Mol Pharmacol 1993; 43:427-433. 
78. Adham N, Kao HT, Schecter LE, Bard J, Olsen M, Urquhart D, et 
al. Cloning of another human serotonin receptor (5-HT1F): a fifth 
5-HT1 receptor subtype coupled to the inhibition of adenylate 
cyclase. Proc Natl Acad Sci U S A 1993; 90:408-412. 
79. Amlaiky N, Ramboz S, Boschert U, Plassat JL, Hen R. Isolation 
of a mouse "5HT1E-like" serotonin receptor expressed 
predominantly in hippocampus. J Biol Chem 1992; 
267:19761-19764. 
80. Heuring RE, Peroutka SJ. Characterization of a novel 
3H-5-hydroxytryptamine binding site subtype in bovine brain 
membranes. J Neurosci 1987; 7:894-903. 
81. Hoyer D, Engel G, Kalkman HO. Characterization of the 5-HT1B 
recognition site in rat brain: binding studies with 
(-)[125I]iodocyanopindolol. Eur J Pharmacol 1985; 118:1-12. 
82. Hoyer D, Engel G, Kalkman HO. Molecular pharmacology of 
5-HT1 and 5-HT2 recognition sites in rat and pig brain 
membranes: radioligand binding studies with [3H]5-HT, 
[3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine 
and [3H]ketanserin. Eur J Pharmacol 1985; 118:13-23. 
83. Leonhardt S, Herrick-Davis K, Titeler M. Detection of a novel 
serotonin receptor subtype (5-HT1E) in human brain: interaction 
with a GTP-binding protein. J Neurochem 1989; 53:465-471. 
84. Middlemiss DN, Fozard JR. 
8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates between 
subtypes of the 5-HT1 recognition site. Eur J Pharmacol 1983; 
90:151-153. 
85. Pazos A, Hoyer D, Palacios JM. The binding of serotonergic 
ligands to the porcine choroid plexus: characterization of a new 
type of serotonin recognition site. Eur J Pharmacol 1984; 
106:539-546. 
86. Pedigo NW, Yamamura HI, Nelson DL. Discrimination of 
multiple [3H]5-hydroxytryptamine binding sites by the neuroleptic 
spiperone in rat brain. J Neurochem 1981; 36:220-226. 
87. Lam S, Shen Y, Nguyen T, Messier TL, Brann M, Comings D, et 
al. A serotonin receptor gene (5HT1A) variant found in a 
Tourette's syndrome patient. Biochem Biophys Res Commun 
1996; 219:853-858. 
88. Nakhai B, Nielsen DA, Linnoila M, Goldman D. Two naturally 
occurring amino acid substitutions in the human 5-HT1A receptor: 
glycine 22 to serine 22 and isoleucine 28 to valine 28. Biochem 
Biophys Res Commun 1995; 210:530-536. 
89. Hoyer D. Functional correlates of serotonin 5-HT1 recognition 
sites. J Recept Res 1988; 8:59-81. 
90. Xie E, Zhu L, Zhao L, Chang LS. The human serotonin 5-HT2C 
receptor: complete cDNA, genomic structure, and alternatively 
spliced variant. Genomics 1996; 35:551-561. 
91. Foguet M, Nguyen H, Le H, Lubbert H. Structure of the mouse 
5-HT1C, 5-HT2 and stomach fundus serotonin receptor genes. 
Neuroreport 1992; 3:345-348. 
92. Julius D, Huang KN, Livelli TJ, Axel R, Jessell TM. The 5HT2 
receptor defines a family of structurally distinct but functionally 
conserved serotonin receptors. Proc Natl Acad Sci U S A 1990; 
87:928-932. 
93. Kursar JD, Nelson DL, Wainscott DB, Cohen ML, Baez M. 
Molecular cloning, functional expression, and pharmacological 
characterization of a novel serotonin receptor 
(5-hydroxytryptamine2F) from rat stomach fundus. Mol 
Pharmacol 1992; 42:549-557. 
94. Pritchett DB, Bach AW, Wozny M, Taleb O, Dal TR, Shih JC, et 
Neurotransmitter 2015; 2: e314. doi: 10.14800/nt.314; © 2015 by Rut Vleugels, et al. 
http://www.smartscitech.com/index.php/nt 
 
Page 12 of 14 
 
al. Structure and functional expression of cloned rat serotonin 
5HT-2 receptor. EMBO J 1988; 7:4135-4140. 
95. Burns CM, Chu H, Rueter SM, Hutchinson LK, Canton H, 
Sanders-Bush E, et al. Regulation of serotonin-2C receptor 
G-protein coupling by RNA editing. Nature 1997; 387:303-308. 
96. Coupar IM, Desmond PV, Irving HR. Human 5-HT(4) and 
5-HT(7) receptor splice variants: are they important? Curr 
Neuropharmacol 2007; 5:224-231. 
97. Sanders-Bush E, Fentress H, Hazelwood L. Serotonin 5-ht2 
receptors: molecular and genomic diversity. Mol Interv 2003; 
3:319-330. 
98. Bender E, Pindon A, van Oers I, Zhang YB, Gommeren W, 
Verhasselt P, et al. Structure of the human serotonin 5-HT4 
receptor gene and cloning of a novel 5-HT4 splice variant. J 
Neurochem 2000; 74:478-489. 
99. Blondel O, Vandecasteele G, Gastineau M, Leclerc S, Dahmoune 
Y, Langlois M, et al. Molecular and functional characterization of 
a 5-HT4 receptor cloned from human atrium. FEBS Lett 1997; 
412:465-474. 
100. Bockaert J, Claeysen S, Sebben M, Dumuis A. 5-HT4 receptors: 
gene, transduction and effects on olfactory memory. Ann N Y 
Acad Sci 1998; 861:1-15. 
101. Claeysen S, Faye P, Sebben M, Taviaux S, Bockaert J, Dumuis A. 
5-HT4 receptors: cloning and expression of new splice variants. 
Ann N Y Acad Sci 1998; 861:49-56. 
102. Claeysen S, Sebben M, Becamel C, Bockaert J, Dumuis A. Novel 
brain-specific 5-HT4 receptor splice variants show marked 
constitutive activity: role of the C-terminal intracellular domain. 
Mol Pharmacol 1999; 55:910-920. 
103. Gerald C, Adham N, Kao HT, Olsen MA, Laz TM, Schechter LE, 
et al. The 5-HT4 receptor: molecular cloning and pharmacological 
characterization of two splice variants. EMBO J 1995; 
14:2806-2815. 
104. Mialet J, Berque-Bestel I, Sicsic S, Langlois M, Fischmeister R, 
Lezoualc'h F. Pharmacological characterization of the human 
5-HT(4(d)) receptor splice variant stably expressed in Chinese 
hamster ovary cells. Br J Pharmacol 2000; 131:827-835. 
105. Van den Wyngaert I, Gommeren W, Verhasselt P, Jurzak M, 
Leysen J, Luyten W, et al. Cloning and expression of a human 
serotonin 5-HT4 receptor cDNA. J Neurochem 1997; 
69:1810-1819. 
106. Vilaro MT, Domenech T, Palacios JM, Mengod G. Cloning and 
characterization of a novel human 5-HT4 receptor variant that 
lacks the alternatively spliced carboxy terminal exon. RT-PCR 
distribution in human brain and periphery of multiple 5-HT4 
receptor variants. Neuropharmacology 2002; 42:60-73. 
107. Berthouze M, Ayoub M, Russo O, Rivail L, Sicsic S, Fischmeister 
R, et al. Constitutive dimerization of human serotonin 5-HT4 
receptors in living cells. FEBS Lett 2005; 579:2973-2980. 
108. Erlander MG, Lovenberg TW, Baron BM, de Lecea L, Danielson 
PE, Racke M, et al. Two members of a distinct subfamily of 
5-hydroxytryptamine receptors differentially expressed in rat 
brain. Proc Natl Acad Sci U S A 1993; 90:3452-3456. 
109. Matthes H, Boschert U, Amlaiky N, Grailhe R, Plassat JL, 
Muscatelli F, et al. Mouse 5-hydroxytryptamine5A and 
5-hydroxytryptamine5B receptors define a new family of 
serotonin receptors: cloning, functional expression, and 
chromosomal localization. Mol Pharmacol 1993; 43:313-319. 
110. Plassat JL, Boschert U, Amlaiky N, Hen R. The mouse 5HT5 
receptor reveals a remarkable heterogeneity within the 5HT1D 
receptor family. EMBO J 1992; 11:4779-4786. 
111. Wisden W, Parker EM, Mahle CD, Grisel DA, Nowak HP, Yocca 
FD, et al. Cloning and characterization of the rat 5-HT5B receptor. 
Evidence that the 5-HT5B receptor couples to a G protein in 
mammalian cell membranes. FEBS Lett 1993; 333:25-31. 
112. Grailhe R, Grabtree GW, Hen R. Human 5-HT(5) receptors: the 
5-HT(5A) receptor is functional but the 5-HT(5B) receptor was 
lost during mammalian evolution. Eur J Pharmacol 2001; 
418:157-167. 
113. Nelson DL. 5-HT5 receptors. Curr Drug Targets CNS Neurol 
Disord 2004; 3:53-58. 
114. Ruat M, Traiffort E, Arrang JM, Tardivel-Lacombe J, Diaz J, 
Leurs R, et al. A novel rat serotonin (5-HT6) receptor: molecular 
cloning, localization and stimulation of cAMP accumulation. 
Biochem Biophys Res Commun 1993; 193:268-276. 
115. Kohen R, Metcalf MA, Khan N, Druck T, Huebner K, Lachowicz 
JE, et al. Cloning, characterization, and chromosomal localization 
of a human 5-HT6 serotonin receptor. J Neurochem 1996; 
66:47-56. 
116. Olsen MA, Nawoschik SP, Schurman BR, Schmitt HL, Burno M, 
Smith DL, et al. Identification of a human 5-HT6 receptor variant 
produced by alternative splicing. Brain Res Mol Brain Res 1999; 
64:255-263. 
117. Bard JA, Zgombick J, Adham N, Vaysse P, Branchek TA, 
Weinshank RL. Cloning of a novel human serotonin receptor 
(5-HT7) positively linked to adenylate cyclase. J Biol Chem 1993; 
268:23422-23426. 
118. Erdmann J, Nothen MM, Shimron-Abarbanell D, Rietschel M, 
Albus M, Borrmann M, et al. The human serotonin 7 (5-HT7) 
receptor gene: genomic organization and systematic mutation 
screening in schizophrenia and bipolar affective disorder. Mol 
Psychiatry 1996; 1:392-397. 
119. Heidmann DE, Metcalf MA, Kohen R, Hamblin MW. Four 
5-hydroxytryptamine7 (5-HT7) receptor isoforms in human and 
rat produced by alternative splicing: species differences due to 
altered intron-exon organization. J Neurochem 1997; 
68:1372-1381. 
120. Lovenberg TW, Baron BM, Delecea L, Miller JD, Prosser RA, 
Rea MA, et al. A novel adenylyl cyclase-activating serotonin 
receptor (5-HT7) implicated in the regulation of mammalian 
circadian rhythms. Neuron 1993; 11:449-458. 
121. Meyerhof W, Obermuller F, Fehr S, Richter D. A novel rat 
serotonin receptor: primary structure, pharmacology, and 
expression pattern in distinct brain regions. DNA Cell Biol 1993; 
12:401-409. 
122. Plassat JL, Amlaiky N, Hen R. Molecular cloning of a mammalian 
serotonin receptor that activates adenylate cyclase. Mol Pharmacol 
1993; 44:229-236. 
123. Ruat M, Traiffort E, Leurs R, Tardivellacombe J, Diaz J, Arrang 
JM, et al. Molecular cloning, characterization, and localization of 
a high-affinity serotonin receptor (5-HT(7)) activating cAMP 
formation. Proc Natl Acad Sci U S A 1993; 90:8547-8551. 
Neurotransmitter 2015; 2: e314. doi: 10.14800/nt.314; © 2015 by Rut Vleugels, et al. 
http://www.smartscitech.com/index.php/nt 
 
Page 13 of 14 
 
124. Shen Y, Monsma FJ, Metcalf MA, Jose PA, Hamblin MW, Sibley 
DR. Molecular cloning and expression of a 5-hydroxytryptamine 7 
serotonin receptor subtype. J Biol Chem 1993; 268:18200-18204. 
125. Tsou AP, Kosaka A, Bach C, Zuppan P, Yee C, Tom L, et al. 
Cloning and expression of a 5-hydroxytryptamine7 receptor 
positively coupled to adenylyl cyclase. J Neurochem 1994; 
63:456-464. 
126. Gellynck E, Laenen K, Andressen KW, Lintermans B, De 
Martelaere K, Matthys A, et al. Cloning, genomic organization 
and functionality of 5-HT(7) receptor splice variants from mouse 
brain. Gene 2008; 426:23-31. 
127. Heidmann DE, Szot P, Kohen R, Hamblin MW. Function and 
distribution of three rat 5-hydroxytryptamine7 (5-HT7) receptor 
isoforms produced by alternative splicing. Neuropharmacology 
1998; 37:1621-1632. 
128. Colas JF, Launay JM, Kellermann O, Rosay P, Maroteaux L. 
Drosophila 5-HT2 serotonin receptor: coexpression with 
fushi-tarazu during segmentation. Proc Natl Acad Sci U S A 1995; 
92:5441-5445. 
129. Saudou F, Boschert U, Amlaiky N, Plassat JL, Hen R. A family of 
Drosophila serotonin receptors with distinct intracellular 
signalling properties and expression patterns. EMBO J 1992; 
11:7-17. 
130. Blenau W, Thamm M. Distribution of serotonin (5-HT) and its 
receptors in the insect brain with focus on the mushroom bodies: 
lessons from Drosophila melanogaster and Apis mellifera. 
Arthropod Struct Dev 2011; 40:381-394. 
131. Clark AC, del Campo ML, Ewer J. Neuroendocrine control of 
larval ecdysis behavior in Drosophila: complex regulation by 
partially redundant neuropeptides. J Neurosci 2004; 
24:4283-4292. 
132. Watanabe T, Aonuma H. Identification and expression analyses of 
a novel serotonin receptor gene, 5-HT2beta, in the field cricket, 
Gryllus bimaculatus. Acta Biol Hung 2012; 63 Suppl 2:58-62. 
133. Watanabe T, Sadamoto H, Aonuma H. Identification and 
expression analysis of the genes involved in serotonin biosynthesis 
and transduction in the field cricket Gryllus bimaculatus. Insect 
Mol Biol 2011; 20:619-635. 
134. Hauser F, Cazzamali G, Williamson M, Park Y, Li B, Tanaka Y, 
Predel R, et al. A genome-wide inventory of neurohormone 
GPCRs in the red flour beetle Tribolium castaneum. Front 
Neuroendocrinol 2008; 29:142-165. 
135. Vleugels R, Lenaerts C, Baumann A, Vanden Broeck J, Verlinden 
H. Pharmacological characterization of a 5-HT1-type serotonin 
receptor in the red flour beetle, Tribolium castaneum. PLoS ONE 
2013; 8:e65052. 
136. Ono H, Yoshikawa H. Identification of amine receptors from a 
swallowtail butterfly, Papilio xuthus L.: cloning and mRNA 
localization in foreleg chemosensory organ for recognition of host 
plants. Insect Biochem Mol Biol 2004; 34:1247-1256. 
137. Guo X, Ma Z, Kang L. Serotonin enhances solitariness in phase 
transition of the migratory locust. Front Behav Neurosci 2013; 
7:129. 
138. Thamm M, Balfanz S, Scheiner R, Baumann A, Blenau W. 
Characterization of the 5-HT1A receptor of the honeybee (Apis 
mellifera) and involvement of serotonin in phototactic behavior. 
Cell Mol Life Sci 2010; 67:2467-2479. 
139. Troppmann B, Balfanz S, Baumann A, Blenau W. Inverse agonist 
and neutral antagonist actions of synthetic compounds at an insect 
5-HT1 receptor. Br J Pharmacol 2010; 159:1450-1462. 
140. Thamm M, Rolke D, Jordan N, Balfanz S, Schiffer C, Baumann 
A, et al. Function and distribution of 5-HT2 receptors in the 
honeybee (Apis mellifera). PLoS One 2013; 8:e82407. 
141. 141.  Witz P, Amlaiky N, Plassat JL, Maroteaux L, Borrelli E, 
Hen R. Cloning and characterization of a Drosophila serotonin 
receptor that activates adenylate cyclase. Proc Natl Aca d Sci U 
S A 1990; 87:8940-8944. 
142. Schlenstedt J, Balfanz S, Baumann A, Blenau W. Am5-HT7: 
molecular and pharmacological characterization of the first 
serotonin receptor of the honeybee (Apis mellifera). J Neurochem 
2006; 98:1985-1998. 
143. Vleugels R, Lenaerts C, Vanden Broeck J, Verlinden H. Signalling 
properties and pharmacology of a 5-HT7 -type serotonin receptor 
from Tribolium castaneum. Insect Mol Biol 2014; 23:230-243. 
144. Pietrantonio PV, Jagge C, McDowell C. Cloning and expression 
analysis of a 5HT7-like serotonin receptor cDNA from mosquito 
Aedes aegypti female excretory and respiratory systems. Insect 
Mol Biol 2001; 10:357-369. 
145. Röser C, Jordan N, Balfanz S, Baumann A, Walz B, Baumann O, 
et al. Molecular and pharmacological characterization of serotonin 
5-HT2alpha and 5-HT7 receptors in the salivary glands of the 
blowfly Calliphora vicina. PLoS ONE 2012; 7:e49459. 
146. Baumann O, Dames P, Kuhnel D, Walz B. Distribution of 
serotonergic and dopaminergic nerve fibers in the salivary gland 
complex of the cockroach Periplaneta americana. BMC Physiol 
2002; 2:9. 
147. Baumann O, Kuhnel D, Dames P, Walz B. Dopaminergic and 
serotonergic innervation of cockroach salivary glands: distribution 
and morphology of synapses and release sites. J Exp Biol 2004; 
207:2565-2575. 
148. Berridge MJ. The role of 5-hydroxytryptamine and cyclic AMP in 
the control of fluid secretion by isolated salivary glands. J Exp 
Biol 1970; 53:171-186. 
149. Rietdorf K, Blenau W, Walz B. Protein secretion in cockroach 
salivary glands requires an increase in intracellular cAMP and 
Ca2+ concentrations. J Insect Physiol 2005; 51:1083-1091. 
150. Molaei G, Lange AB. The association of serotonin with the 
alimentary canal of the African migratory locust, Locusta 
migratoria: distribution, physiology and pharmacological profile. 
J Insect Physiol 2003; 49:1073-1082. 
151. Vanhoenacker P, Haegeman G, Leysen JE. 5-HT7 receptors: 
current knowledge and future prospects. Trends Pharmacol Sci 
2000; 21:70-77. 
152. Arvidsson LE, Hacksell U, Nilsson JL, Hjorth S, Carlsson A, 
Lindberg P, et al. 8-Hydroxy-2-(di-n-propylamino)tetralin, a new 
centrally acting 5-hydroxytryptamine receptor agonist. J Med 
Chem 1981; 24:921-923. 
153. Krobert KA, Bach T, Syversveen T, Kvingedal AM, Levy FO. 
The cloned human 5-HT7 receptor splice variants: a comparative 
characterization of their pharmacology, function and distribution. 
Naunyn Schmiedebergs Arch Pharmacol 2001; 363:620-632. 
154. Thomas DR, Gittins SA, Collin LL, Middlemiss DN, Riley G, 
Hagan J, et al. Functional characterisation of the human cloned 
Neurotransmitter 2015; 2: e314. doi: 10.14800/nt.314; © 2015 by Rut Vleugels, et al. 
http://www.smartscitech.com/index.php/nt 
 
Page 14 of 14 
 
5-HT7 receptor (long form); antagonist profile of SB-258719. Br J 
Pharmacol 1998; 124:1300-1306. 
155. Fitzgerald LW, Conklin DS, Krause CM, Marshall AP, Patterson 
JP, Tran DP, et al. High-affinity agonist binding correlates with 
efficacy (intrinsic activity) at the human serotonin 5-HT2A and 
5-HT2C receptors: evidence favoring the ternary complex and 
two-state models of agonist action. J Neurochem 1999; 
72:2127-2134. 
156. Johnson M, Sonsalla PK, Letter AA, Hanson GR, Gibb JW. Role 
of the 5-HT2 receptor in the methamphetamine-induced 
neurochemical alterations. J Pharmacol Exp Ther 1994; 
270:97-103. 
157. Kursar JD, Nelson DL, Wainscott DB, Baez M. Molecular 
cloning, functional expression, and mRNA tissue distribution of 
the human 5-hydroxytryptamine2B receptor. Mol Pharmacol 
1994; 46:227-234. 
158. Newman-Tancredi A, Gavaudan S, Conte C, Chaput C, Touzard 
M, Verriele L, et al. Agonist and antagonist actions of 
antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS 
binding study. Eur J Pharmacol 1998; 355:245-256. 
159. Newman-Tancredi A, Nicolas JP, Audinot V, Gavaudan S, 
Verriele L, Touzard M, et al. Actions of alpha2 adrenoceptor 
ligands at alpha2A and 5-HT1A receptors: the antagonist, 
atipamezole, and the agonist, dexmedetomidine, are highly 
selective for alpha2A adrenoceptors. Naunyn Schmiedebergs Arch 
Pharmacol 1998; 358:197-206. 
160. Lovell PJ, Bromidge SM, Dabbs S, Duckworth DM, Forbes IT, 
Jennings AJ, et al. A novel, potent, and selective 5-HT(7) 
antagonist: 
(R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl) 
phenol (SB-269970). J Med Chem 2000; 43:342-345. 
161. Thomas DR, Atkinson PJ, Ho M, Bromidge SM, Lovell PJ, 
Villani AJ, et al. [(3)H]-SB-269970--A selective antagonist 
radioligand for 5-HT(7) receptors. Br J Pharmacol 2000; 
130:409-417. 
162. Chemel BR, Roth BL, Armbruster B, Watts VJ, Nichols DE. 
WAY-100635 is a potent dopamine D4 receptor agonist. 
Psychopharmacology (Berl) 2006; 188:244-251. 
163. Foong JP, Bornstein JC. 5-HT antagonists NAN-190 and SB 
269970 block alpha2-adrenoceptors in the guinea pig. Neuroreport 
2009; 20:325-330. 
164. Yoshio R, Taniguchi T, Itoh H, Muramatsu I. Affinity of serotonin 
receptor antagonists and agonists to recombinant and native 
alpha1-adrenoceptor subtypes. Jpn J Pharmacol 2001; 86:189-195. 
165. Burris KD, Pacheco MA, Filtz TM, Kung MP, Kung HF, Molinoff 
PB. Lack of discrimination by agonists for D2 and D3 dopamine 
receptors. Neuropsychopharmacology 1995; 12:335-345. 
166. Freedman SB, Patel S, Marwood R, Emms F, Seabrook GR, 
Knowles MR, et al. Expression and pharmacological 
characterization of the human D3 dopamine receptor. J Pharmacol 
Exp Ther 1994; 268:417-426. 
167. MacKenzie RG, VanLeeuwen D, Pugsley TA, Shih YH, Demattos 
S, Tang L, et al. Characterization of the human dopamine D3 
receptor expressed in transfected cell lines. Eur J Pharmacol 1994; 
266:79-85. 
168. Sunahara RK, Guan HC, O'Dowd BF, Seeman P, Laurier LG, Ng 
G, et al. Cloning of the gene for a human dopamine D5 receptor 
with higher affinity for dopamine than D1. Nature 1991; 
350:614-619. 
169. Lee DW, Pietrantonio PV. In vitro expression and pharmacology 
of the 5-HT7-like receptor present in the mosquito Aedes aegypti 
tracheolar cells and hindgut-associated nerves. Insect Mol Biol 
2003; 12:561-569. 
170. Artigas F. 5-HT and antidepressants: new views from 
microdialysis studies. Trends Pharmacol Sci 1993; 14:262. 
171. Celada P, Puig M, Amargos-Bosch M, Adell A, Artigas F. The 
therapeutic role of 5-HT1A and 5-HT2A receptors in depression. J 
Psychiatry Neurosci 2004; 29:252-265. 
172. Celada P, Puig MV, Artigas F. Serotonin modulation of cortical 
neurons and networks. Front Integr Neurosci 2013; 7:25. 
173. Marek GJ. Behavioral evidence for mu-opioid and 5-HT2A 
receptor interactions. Eur J Pharmacol 2003; 474:77-83. 
174. Quesseveur G, Nguyen HT, Gardier AM, Guiard BP. 5-HT2 
ligands in the treatment of anxiety and depression. Expert Opin 
Investig Drugs 2012; 21:1701-1725. 
175. Vidal R, Diaz A, Pazos A, Castro E. Region-specific regulation of 
5-HT1B receptors in the rat brain by chronic venlafaxine 
treatment. Psychopharmacology (Berl) 2013; 229:177-185. 
176. Mitsikostas DD, Tfelt-Hansen P. Targeting to 5-HT1F receptor 
subtype for migraine treatment: lessons from the past, implications 
for the future. Cent Nerv Syst Agents Med Chem 2012; 
12:241-249. 
177. Briejer MR, Prins NH, Schuurkes JA. Effects of the enterokinetic 
prucalopride (R093877) on colonic motility in fasted dogs. 
Neurogastroenterol Motil 2001; 13:465-472. 
178. Jandacek RJ, Anderson N, Liu M, Zheng S, Yang Q, Tso P. 
Effects of yo-yo diet, caloric restriction, and olestra on tissue 
distribution of hexachlorobenzene. Am J Physiol Gastrointest 
Liver Physiol 2005; 288:G292-G299. 
179. Verlinden H, Vleugels R, Zels S, Dillen S, Lenaerts C, Crabbé K, 
et al. Neurohormone receptors as targets for the control of insect 
pest. Adv Insect Physiol 2014; 46:167-303. 
